PACS Group (PACS) CEO receives 234,397 restricted stock units in equity grant

Rhea-AI Filing Summary

PACS Group, Inc. director and Co-Founder, CEO & Chairman Murray Jason Hulse reported an equity compensation award in the form of restricted stock units. He received 234,397 RSUs of Common Stock at a grant price of $0.00 per share, classified as a grant or award acquisition. These RSUs will vest in substantially equal annual installments on the first, second, and third anniversaries of March 24, 2026, subject to his continued service. Following this grant, his directly held Common Stock position reported in this filing is 55,081,532 shares.

Insider Trade Summary

1 transaction reported

Mixed 1 txn

Insider Murray Jason Hulse

Role Co-Founder, CEO & Chairman

Type	Security	Shares	Price	Value
Grant/Award	Common Stock	234,397	$0.00	--

Holdings After Transaction: Common Stock — 55,081,532 shares (Direct)

Footnotes (1)

1. [object Object]

Form 4 Insider Transactions: What Each Field Means →

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

Murray Jason Hulse

(Last) (First) (Middle)

C/O PACS GROUP, INC.

90 S. 400 W. SUITE 700

(Street)

SALT LAKE CITY UTAH 84101

(City) (State) (Zip)

UNITED STATES

(Country)

2. Issuer Name and Ticker or Trading Symbol
PACS Group, Inc. [ PACS ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

X	Director	X	10% Owner
X	Officer (give title below)		Other (specify below)
	Co-Founder, CEO & Chairman

2a. Foreign Trading Symbol

3. Date of Earliest Transaction (Month/Day/Year)
03/24/2026

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

4. If Amendment, Date of Original Filed (Month/Day/Year)

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price
Common Stock	03/24/2026		A		234,397(1)	A	$0	55,081,532	D

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares

Explanation of Responses:

1. Represents restricted stock units ("RSUs") for which the Reporting Person is entitled to receive one (1) share of Common Stock for each RSU upon vesting. The RSUs will vest in substantially equal annual installments on the first, second, and third anniversaries of March 24, 2026, subject to the Reporting Person's continued service through the applicable vesting date.

Remarks:

	/s/ John Mitchell, Attorney-in-Fact	03/26/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
* Form 4: SEC 1474 (03-26)

FAQ

What insider transaction did PACS (PACS) report for Murray Jason Hulse?

PACS reported that Co-Founder, CEO & Chairman Murray Jason Hulse received 234,397 restricted stock units of Common Stock as an equity award. The RSUs were granted at $0.00 per share as compensation, not as an open‑market purchase.

How do Murray Jason Hulse’s new PACS RSUs vest?

The 234,397 PACS restricted stock units vest in substantially equal annual installments on the first, second, and third anniversaries of March 24, 2026. Vesting is conditioned on Hulse’s continued service with the company through each applicable vesting date.

How many PACS shares does Murray Jason Hulse hold after this Form 4?

After this award, Murray Jason Hulse is reported as directly holding 55,081,532 shares of PACS Common Stock. This figure reflects his position following the RSU grant reported in the Form 4 and helps indicate the scale of his overall ownership stake.

Was the PACS insider transaction an open-market stock purchase or sale?

The PACS insider transaction was not an open‑market trade. It was coded as “A” for a grant, award, or other acquisition, meaning Hulse received 234,397 restricted stock units as equity compensation rather than buying or selling shares in the market.

What does each PACS RSU granted to Murray Jason Hulse represent?

Each PACS restricted stock unit granted to Hulse entitles him to receive one share of Common Stock upon vesting. This structure aligns his compensation with future company performance and continued service, since actual shares are delivered only as the RSUs vest over time.